Blood Substitutes

Also found in: Dictionary, Thesaurus, Medical, Legal, Wikipedia.

Blood Substitutes


plasma substitutes, agents used for therapeutic purposes instead of blood transfusion, for the dilution of banked whole blood, and in cases of shock, blood loss, burn, anemias, and purulent septic diseases.

The injection of blood substitutes is often combined with the transfusion of donor blood. Blood substitutes are divided, according to action, into antishock, detoxification, and parenteral-feeding preparations. Many blood substitutes have compound effects.

The most commonly used antishock preparations are polyglucin (dextran), polyvinylpyrrolidone, and gelatin preparations. Polyglucin is a polymer of glucose that is synthesized by the bacteria Leuconostoc mesenteroides. Soviet polyglucin does not decrease the function of the coagulation system. Polyvinylpyrrolidone is a polymer that consists of 250 to 300 chains of vinylpyrrolidone. Gelatinol, which is produced from modified gelatin, is used in extracorporeal blood circulation (in heart operations).

Detoxification blood substitutes are represented by preparations of low-molecular-weight polyvinylpyrrolidone (molecular weight, 10,000–12,000). The preparations (in particular, Gemodez) contain 6-percent low-molecular-weight polyvinylpyrrolidone and saline or glucose solutions. They are highly effective in detoxification with radiation sickness and burn diseases. Low-molecular-weight polyvinylpyrrolidone has a diuretic effect and reduces stasis in the capillaries. Protein preparations also have a detoxifying effect.

The preparations used in parenteral feeding include native protein products (plasma and albumin) and protein hydrolysates (casein hydrolysate of the Central Order of Lenin Scientific Research Institute of Hematology and Blood Transfusion, hydroly-sate L-103, and aminopeptide). These are used to treat weakened postoperative patients, burns of the esophagus, hypoproteinemic states of various etiology, and burn diseases.

Fatty emulsions (from 10 to 20 percent fat) from cottonseed oil (Lipofundinum in the Federal Republic of Germany; Lipomulum in the USA) and soybean oil (Intralipidum in Sweden) are also manufactured as parenteral substitutes. Lipomaiz, made from corn oil at the Leningrad Blood Transfusion Institute, contains 10 percent fat. These emulsions are used parenterally to increase the body’s energy resources. The combined use of hydrolysates and fat emulsions is recommended.


Filatov, A. N., Z. A. Chaplygina, and M. E. Depp. Belkovye gidrolizaty. [Leningrad] 1968.
Petrov, I. R., V. A. Bondina, and E. A. Senchilo. Plazmozameshchaiushchie rastvory pri lechenii krovopoteri i shoka. Leningrad, 1969.
Spravochnik po krovezameniteliam i preparatam krovi. Edited by A. I. Burnazian. Moscow, 1969.
References in periodicals archive ?
Certain of the statements made in this press release are forward-looking such as those, among others, relating to the development of drug delivery and blood substitute products, and the Company's financial strength and future success.
HemoBioTech's Human Blood Substitute, HemoTech, Highlighted in Scientific American Online, November 20, 2007: HemoTech, potentially the first viable substitute for human blood, was highlighted in the November 13, 2007 online edition of Scientific American as the lead story in its news section.
The pivotal trials were the first Phase III study to include direct replacement of blood in large volumes, and mark a milestone in medicine's search for an oxygen carrying blood substitute, the company said today.
com), a developmental biopharmaceutical company focused on developing and commercializing potentially the first viable human blood substitute, was featured nationally on Fox News.
Northfield, with its blood substitute PolyHeme, is still the frontrunner.
Photo: Hemoglobin encapsulated in liposomes may make an excellent blood substitute if it can be preserved well.
And a type-free blood substitute would bypass many of the problems of finding compatible donors for recipients with unusual antibodies.
The blood substitute can prove to be a boon for many patients who face the problem of unavailability of blood in emergency situations.
1 The contract is successive supplies of medicines, infusion solutions and blood substitutes for particular nutritional products, pharmaceutical raw materials and packaging, vaccines, surgical and specialist surgical suture materials and containers for blood to the Hospital Pharmacy Healthcare Ministry of the Interior in Wroclaw, character matters: ZZ-APT -2375-4 / 14.
He will address the quest for a substitute for human blood and present key features of HemoTech(TM), the novel blood substitute under development by HemoBioTech.
The company believes that HemoTech may possess properties that diminish the intrinsic toxicities which have plagued other attempts at developing blood substitutes, based upon pre-clinical and initial human clinical trials undertaken outside the United States by prior holders of this technology.
Later, they demonstrated definitively that many of the problems associated with blood substitutes were caused by nitric oxide scavenging and designed a recombinant hemoglobin that significantly decreased that activity.